03:45 AM EDT, 10/27/2025 (MT Newswires) -- MapLight Therapeutics (MPLT) said Sunday it has priced its initial public offering of 14.8 million shares at $17 per share.

The company said it also granted underwriters a 30-day option to purchase up to 2.2 million additional shares.

Alongside the IPO, MapLight said it sold 476,707 shares in a private placement to Goldman Sachs affiliates at the same price.

Total gross proceeds from both deals are expected to be $258.9 million, the company said.

It added that the stock will begin trading Monday on the Nasdaq Global Market under the ticker 'MPLT', with the offering expected to close Tuesday.